Evidence map›Paper›PMID 37009460›Full record

ArticleFrontiers in aging neuroscience2023

Retinal fingerprints of ALS in patients: Ganglion cell apoptosis and TDP-43/p62 misplacement.

Natalia Pediconi, Ylenia Gigante, Silvia Cama, Martina Pitea, Lorenza Mautone, Giancarlo Ruocco, Silvia Ghirga, Silvia Di Angelantonio

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Natalia PediconiCenter for Life Nano- and Neuro-Science of Istituto Italiano di Tecnologia (IIT), Rome, Italy.
Ylenia GiganteCenter for Life Nano- and Neuro-Science of Istituto Italiano di Tecnologia (IIT), Rome, Italy.
Silvia CamaDepartment of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.
Martina PiteaCenter for Life Nano- and Neuro-Science of Istituto Italiano di Tecnologia (IIT), Rome, Italy.
Lorenza MautoneCenter for Life Nano- and Neuro-Science of Istituto Italiano di Tecnologia (IIT), Rome, Italy.
Giancarlo RuoccoCenter for Life Nano- and Neuro-Science of Istituto Italiano di Tecnologia (IIT), Rome, Italy.
Silvia GhirgaCenter for Life Nano- and Neuro-Science of Istituto Italiano di Tecnologia (IIT), Rome, Italy.
Silvia Di AngelantonioCenter for Life Nano- and Neuro-Science of Istituto Italiano di Tecnologia (IIT), Rome, Italy.
Italian Institute of Technology · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neuron function. Although ophthalmic deficits are not considered a classic symptom of ALS, recent studies suggest that changes in retinal cells, similar to those in the spinal cord motor neurons, have been observed in postmortem human tissues and animal models. Methods: In this study, we examined by immunofluorescence analysis the retinal cell layers of sporadic ALS patients in post-mortem retinal slices. We evaluated the presence of cytoplasmic TDP-43 and SQSTM1/p62 aggregates, activation of the apoptotic pathway, and microglia and astrocytes reactivity. Results: We found in the retinal ganglion cell layer of ALS patients the increase of mislocalized TDP-43, SQSTM1/p62 aggregates, activation of cleaved caspase-3, and microglia density, suggesting that retinal changes can be used as an additional diagnostic tool for ALS. Discussion: The retina is considered part of the central nervous system, and neurodegenerative changes in the brain may be accompanied by structural and possibly functional changes in the neuroretina and ocular vasculature. Therefore, using

Indexed as

ALSbiomarkersmicroglianeurodegenerationneuronsprotein inclusionsretinaTDP-43

Identifiers

PMID37009460
PMCPMC10061015
OpenAlexW4327604700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.